Augmedix (Nasdaq: AUGX), a healthcare technology company that
delivers industry-leading, ambient medical documentation and data
solutions, announced today that it has been piloting Google Cloud’s
Med-PaLM 2 and will integrate Google Cloud’s newly introduced MedLM
technology into its technology stack. This model suite uses the
latest AI developments adapted for healthcare use cases and meets
Augmedix’s stringent requirements around AI safety, compliance, and
enterprise scalability.
MedLM, now generally available to allowlisted
customers, builds on Google Cloud’s Med-PaLM 2 generative AI (gen
AI) large language model (LLM). MedLM is purposefully built to
provide high-quality generative AI output in the medical domain. It
comes with a suite of medically-tuned models and APIs for different
use cases, delivering the best of Google Cloud’s gen AI
capabilities to the healthcare industry. Importantly, Augmedix uses
Google Cloud’s Vertex AI platform to develop its own proprietary
solutions using training data created by Augmedix’s existing
technology, which generates 70,000 notes per week and spans more
than 30 specialties.
"Generative AI solutions for use in healthcare
delivery require a more tailored and precise approach than general
purpose LLMs, which is why we value our strategic partnership with
Google Cloud,” said Augmedix Founder, Director, and Chief Strategy
Officer Ian Shakil. “Google Cloud has established its leadership as
an AI innovator with solutions specifically designed to address the
needs of healthcare providers.”
In recent months, Google Cloud has been closely
iterating with Augmedix to ensure optimized performance in
challenging, real-world medical use cases through ambient
documentation, where relevant medical information is recorded and
captured from natural clinician-patient conversations at the point
of care. Augmedix now plans to incorporate MedLM into its machine
learning platform across its suite of products. Integrating MedLM
into its ambient medical documentation products will elevate the
quality of medical note output, provide faster turnaround times,
and enable Augmedix to rapidly expand into more sub-specialties
through 2024. This new technology will be integrated into the
recently launched Augmedix Go, a clinician-controlled mobile app
that instantaneously creates a fully automated draft medical note
after each patient visit, and will soon be incorporated into all
Augmedix documentation products.
"Generative AI has enormous potential to
automate one of the most time-intensive and tedious tasks in
healthcare—capturing accurate medical notes of doctor-patient
interactions,” said Thomas Kurian, CEO, Google Cloud. “We are
committed to advancing solutions that allow organizations like
Augmedix and its health system clients to address these and other
challenges in the healthcare industry. Our launch of MedLM and
partnership with Augmedix exemplifies our commitment to solve these
once-intractable problems."
This integration of MedLM is an exciting
milestone for Augmedix customers such as HCA Healthcare, who
introduced Augmedix’s documentation products to four hospitals
earlier in 2023.
“We’ve introduced Augmedix’s technology into
some of our hospitals this year,” said Michael J. Schlosser, MD,
MBA, FAANS, Senior Vice President of Care Transformation and
Innovation, HCA Healthcare. “I’m pleased to see that our innovative
partners at Google Cloud and Augmedix are continuously focused on
advancing their products to streamline workflows and allow
caregivers to focus on what matters most, patient care.”
Google Cloud’s customers retain control over
their data. In healthcare settings, access and use of patient data
are protected through the implementation of Google Cloud’s reliable
infrastructure and secure data storage that support HIPAA
compliance, along with each customer’s security, privacy controls,
and processes.
About AugmedixAugmedix (Nasdaq:
AUGX) delivers industry-leading, ambient medical documentation and
data solutions to healthcare systems, physician practices,
hospitals, and telemedicine practitioners.
Augmedix is on a mission to help clinicians and
patients form a human connection by seamlessly integrating our
technology at the point of care. Augmedix’s proprietary platform
digitizes natural clinician-patient conversations, which are
converted into comprehensive medical notes and structured data in
real time. The company’s platform uses automatic speech
recognition, and natural language processing, including large
language models, to generate accurate and timely medical notes that
are transferred into the EHR.
Augmedix’s products relieve clinicians of
administrative burden, in turn, reducing burnout, increasing
clinician efficiency and improving patient access. Through
Augmedix’s proprietary platform and bi-directional communication
channel, Augmedix is ideally suited to serve as the vehicle for
change at the point of care.
Augmedix is headquartered in San Francisco, CA,
with offices around the world. To learn more, visit
www.augmedix.com.
Contact Information
Investors:Matt Chesler, CFAFNK IR646-809-2183augx@fnkir.com
investors@augmedix.com
Media:Kaila GrafemanAugmedixpr@augmedix.com
Forward-Looking Statements
This press release contains “forward-looking
statements” that involve a number of risks and uncertainties. Words
such as “believes,” “may,” “will,” “estimates,” “potential,”
“continues,” “anticipates,” “intends,” “expects,” “could,” “would,”
“projects,” “plans,” “targets,” “excited,” “optimistic,” and
variations of such words and similar expressions are intended to
identify forward-looking statements. Such forward-looking
statements include, without limitation, statements regarding
Augmedix’s plans to integrate MedLM into Augmedix’s technology
stack; statements that MedLM will further advance Augmedix’s
ambient medical documentation product performance; statements
regarding Augmedix’s plans to incorporate MedLM into its machine
learning platform across its suite of documentation products;
statements regarding MedLM delivering the best of Google Cloud’s
gen AI capabilities to the healthcare industry and Google Cloud
establishing its leadership as an AI innovator with solutions
specifically designed to address the needs of healthcare providers;
statements regarding integration with MedLM elevating the quality
of medical note output, providing faster turnaround times, and
enabling Augmedix to rapidly expand into more sub-specialties in
2024; statements regarding Augmedix’s plans to incorporate MedLM
into all Augmedix documentation products; and statements regarding
the expected benefits of the MedLM integration with Augmedix’s
platform. Actual results could differ materially from those stated
or implied in forward-looking statements due to a number of
factors, including but not limited to, risks detailed in our most
recent Form 10-K filed with the U.S. Securities and Exchange
Commission on April 17, 2023, as well as other documents that may
be filed by us from time to time with the U.S. Securities and
Exchange Commission. The forward-looking statements included in
this press release represent our views as of the date of this press
release. We undertake no intention or obligation to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise. These forward-looking
statements should not be relied upon as representing our views as
of any date subsequent to the date of this press release.
Augmedix (NASDAQ:AUGX)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Augmedix (NASDAQ:AUGX)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024